CancerLivER: Biomarker Card

Biomarker Card: Comprehensive information about a biomarker


Biomarker ID 2306
Detailed information
CancerLivER ID2306
Biomarker EPO
Biomarker Name/Symbol (given in Publication)EPO
BiomoleculeRNAs
SubjectHuman
Degree of ValidityPotential marker for cirrhosis; but not validated on independent dataset
Experimental Conditiondysplasia v/s early/late HCC and normal
Cancer typeHepatocellular carcinoma
RegulationUpregulated in dysplasia v/s control and early/advanced HCC
Level of significance p < 0.05
SourceTissue
PMID17393520
Type of BiomarkerDiagnostic
PathwayJak-STAT pathway
Cohort75 samples (48 patients): Sixty-five samples were obtained from 38 patients with HCV infection representing 13 samples from cirrhotic tissue, 17 dysplastic nodules, and 35 HCCs; samples of normal tissue obtained from the healthy livers of 10 patients undergoing resection for hepatic hemangioma (1),
SensitivityNA
SpecificityNA
AccuracyNA
AUCNA
Diseasedysplasia v/s early/late HCC and normal
Year of Publication2007
Clinical trialNO
Clinical trial (NCT Number)NA

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top